期刊文献+

血液灌流联合连续性静脉-静脉血液滤过对严重脓毒症患者的效果分析 被引量:9

Analysis of the effect of hemoperfusion combined with continuous veno-venous hemofiltration on patients with severe sepsis
下载PDF
导出
摘要 目的探讨血液灌流联合连续性静脉-静脉血液滤过治疗在严重脓毒症患者中的临床效果。方法将2016年1月—2018年9月就诊于本院的90例严重脓毒症患者随机分为行常规治疗的对照组与行血液灌流联合连续性静脉-静脉血液滤过治疗的观察组,对比分析两组患者的治疗效果。结果血液灌流联合连续性静脉-静脉血液滤过组患者Hb、WBC、BUN、SCr、LAC、hcCRP以及尿量等各项指标治疗后较治疗前均显著改善(P<0.05),且改善情况显著优于对照组(P<0.05);在TNF-α、IL-6及IL-8等炎性因子改善方面,血液灌流联合连续性静脉-静脉血液滤过组患者也显著优于对照组(P<0.05);在重症医学科住院时间、总住院时间及患者死亡率方面,血液灌流联合连续性静脉-静脉血液滤过组均显著优于对照组(P<0.05)。结论对严重脓毒症患者进行血液灌流联合连续性静脉-静脉血液滤过治疗,能够有效改善患者的临床症状,提高其临床治疗效果及免疫功能,利于患者的早日康复,值得广泛应用于临床。 Objective To explore the clinical effect of hemoperfusion(HP) combined with continuous venous venous hemofiltration(CVVH)treating severe sepsis.Methods:90 patients with severe sepsis in our hospital from January 2016 to September 2018 were randomly divided into the control group treated with routine therapy and the observation group treated with hemoperfusion combined with continuous veno-venous hemofiltration.The therapeutic effects of the two groups were compared and analyzed.Results:After treatment,the indexes of Hb,WBC,BUN,SCr,LAC,hcCRP and urine volume were significantly improved in patients with hemoperfusion combined with continuous veno-venous hemofiltration(P<0.05),and the improvement was significantly better than that of the control group(P <0.05).In the improvement of inflammatory factors such as TNF-a,IL-6 and IL-8,hemoperfusion combined with continuous veno-venous hemofiltration group was significantly improved(P<0.05).It was also significantly better than that of the control group(P<0.05).In terms of hospitalization time,total hospitalization time and mortality of patients in the critical medicine department,the combination of hemoperfusion and continuous veno-venous hemofiltration group was significantly better than that of the control group(P<0.05).Conclusion:Hemoperfusion combined with continuous veno-venous hemofiltration for severe sepsis patients can effectively improve the clinical symptoms,improve the clinical efficacy and immune function,and facilitate the early recovery of patients.It is worth being widely used in clinical practice.
作者 尤伟艳 许航 YOU Wei yan;XU Hang(Department of Critical Care Medicine,The First Affiliated Hospital of Shihezi University School of Medicine,832000)
出处 《新疆医学》 2019年第3期218-220,共3页 Xinjiang Medical Journal
基金 国家自然科学基金青年科学基金 (项目编号:81801957)
关键词 脓毒症 连续性静脉-静脉血液滤过 血液灌流 Sepsis Continuous Veno-venous Hemofiltration Hemoperfusion
  • 相关文献

参考文献5

二级参考文献42

  • 1Bone RC,Balk RA,Cerra FB,et al.Defintion for sepsis and organ failure and guidelinos for the use of innovafive therapics in sepsis.chest 1992,10(1):1644-1655.
  • 2Rangel Frausto MS,pitter D,Costigan M.et al,The netural history of the systemic inflam matory response syndrome(SIRS):a prospective study.JAMA,1995,27(3):117-123.
  • 3Riedemann NC,auo RF,Ward PA.Novel strategeis for treament of sepsis.Nat Med,2003,9(5):517-523.
  • 4Dellinger RP,Levy MM,Rhodes A. Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock,2012[J].Intensive Care Medicine,2013.165-228.
  • 5Galvagno SM Jr, Hong CM, Lissauer ME, et al. Practical con- siderations for the dosing and adjustment of continuous renal re- placement therapy in the intensive care unit [ J ]. J Crit Care, 2013,28 (6) : 1019-1026.
  • 6Goldstein SL. Continuous renal replacement therapy : mechanism of clearance, fluid removal, indications and outcomes [ J ]. Curr Opin Pediatr,2011,23 ( 2 ) : 181-185.
  • 7Zhang W, Chen X, Huang L, et al. Severe sepsis:Low expre- ssion of the renin-angiotensin system is associated with poor prognosis [ J ]. Exp Ther Med,2014,7 (5) : 1342-1348.
  • 8Dial S, Nessim S J, Kezouh A, et al. Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis [J]. Br J Clin Pharmacol,2014,78(5) :1151-1158.
  • 9Goldstein B, Giroir B, Randolph A, et al. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics [ J ]. Pediatr Crit Care Med, 2005,6 (1) :2-8.
  • 10Tamion F, Le Cam-Duchez V, Menard JF, et al. Erythropoietin and renin as biological markers in critically ill patients[ J]. Crit Care,2004,8 ( 5 ) : R328-335.

共引文献714

同被引文献93

引证文献9

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部